Currax Pharma
Currax Pharmaceuticals is a US-based specialty pharmaceutical company focused on expanding access to prescription medicines for chronic health conditions, including obesity, migraine, and sleep disorders. Its leading product, CONTRAVE®, is a prescription treatment for chronic weight management.
Visit WebsiteAbout Currax Pharma
Currax Pharmaceuticals LLC is a specialty pharmaceutical company headquartered in Brentwood, Tennessee. The company focuses on acquiring and commercializing prescription medicines for chronic and other significant health conditions, with an emphasis on patient access and commercial execution.
Its portfolio includes CONTRAVE®, an extended-release combination of naltrexone hydrochloride and bupropion hydrochloride for chronic weight management, as well as ONZETRA® Xsail® for migraine, SILENOR® for sleep, and TREXIMET® for migraine. Currax also maintains a development pipeline focused on obesity and related treatment areas.
The company works across pharmaceutical commercialization, healthcare-provider education, patient access, and strategic partnerships.